ISS backs Pfizer’s $179m ResApp takeover offer
MELBOURNE: Institutional Shareholder Services has backed Pfizer’s $179m takeover of a fledgling biotech ... read more
Genesis Capital backs in clinical research with Crux Biolabs deal
MELBOURNE: The biolabs deals are back! After a short hiatus, specialist healthcare private ... read more
Appen’s latest downgrade points to bigger problem
MELBOURNE: ASX-listed AI data firm Appen clearly has several serious problems, starting with ... read more
